SonoThera announced that it received exclusive global commercial licensing rights from GE HealthCare (NYSE:GEHC) for two of its microbubble products. South San Francisco-based SonoThera received the rights for the Optison and Sonazoid microbubble products. It uses them in the development of its novel, ultrasound-guided nonviral gene therapy platform. According to SonoThera co-founder and CEO Kenneth […]
GE Healthcare
GE HealthCare, Ulrich ink deal to offer multi-dose contrast media injector in U.S.
GE HealthCare today announced an agreement with Ulrich Medical to offer a GE HealthCare branded contrast media injector in the U.S. The CT motion multi-dose syringeless injector delivers iodinated contrast media for computed tomography (CT) imaging procedures. It helps to reduce procedure setup time and increase patient throughput by eliminating time-consuming preparation steps. Additionally, it […]
FDA approves GE Healthcare software that automates anesthesia, reduces greenhouse gas emissions during surgery
GE Healthcare recently announced that it received FDA premarket approval for its End-tidal (Et) Control software for general anesthesia delivery. The software is cleared for use with GE Healthcare’s Aisys CS2 anesthesia delivery system. The Chicago-based company initially released the technology in Europe in 2010 and is currently used in over 100 countries. Get the full […]
GE Healthcare wins FDA premarket approval for software used in anesthesia delivery system
GE Healthcare (NYSE:GE) announced today that the FDA granted premarket approval for its End-tidal (Et) control software in anesthesia delivery. Approval covers the use of the Et control software for general anesthesia delivery on GE Healthcare’s Aisys CS2 anesthesia delivery system. The technology was released in Europe in 2010 and today can be used to […]
GE Healthcare, Blue Earth Diagnostics ink UK manufacturing deal
Blue Earth Diagnostics and GE Healthcare (NYSE:GE) said today that the group has inked a deal to establish the manufacturing of Blue Earth Diagnostic’s positron emission tomography imaging product, Axumin, in the U.K. The agreement with GE Healthcare is part of Blue Earth Diagnostics’ move towards commercializing Axumin since it won marketing authorization from the European […]
DeviceTalks Boston: Here’s what you need to know
DeviceTalks Boston on Oct 2. will give attendees the chance to see some of the best minds in medtech live. There will be learning and networking opportunities galore. Read on and meet some of the top medical device leaders and experts who will be speaking – and discover other highlights from the upcoming show. Next>> (See […]
GE Healthcare wins FDA nod for Visipaque coronary CT angiography injection
GE Healthcare (NYSE:GE) said today that it won an indication approval from the FDA for its Visipaque injection imaging agent. The 320 milligram iodine per milliliter injection is an iso-osmolar agent that the federal watchdog approved for use in coronary computed tomography angiography. The new indication allows doctors to image coronary arteries of patients to help […]
Carticept closes $10M round from SonoSite, others | Funding Roundup
Carticept Medical closed a $10 million financing led by existing investors Domain Associates, New Enterprise Associates and SonoSite Inc.
The Alpharetta, Ga.-based company said it will use the proceeds to fund the commercial launch of its Navigator computer-controlled drug delivery system. The device uses ultrasound guidance to deliver medications for joint pain.
